Skip to main content
. 2019 May 16;10(6):1461–1468. doi: 10.1111/1759-7714.13095

Figure 2.

Figure 2

Progression‐free survival (PFS) of (a) second or later‐line treatment Inline graphic Censored; and (b) second or later‐line treatment stratified by mutation type. Inline graphic Common sensitive mutations, Inline graphic uncommon sensitive mutations, Inline graphic Censored. CI, confidence interval.